CABB to Acquire KemFine Group

CABB, a German provider of chemical building blocks, fine and specialty chemicals and custom manufacturing solutions, has acquired KemFine Group through its Swiss subsidiary AXCABB for an estimated €140 million, according to a person with knowledge of the deal. The transaction is subject to standard competition clearances.

KemFine Group focuses on the custom manufacturing of fine chemicals for the global agro and pharma industry. It is headquartered in Helsinki and operates a production facility in Kokkola, Finland. It has approximately 190 employees and in 2010 had sales of €81 million.

CABB is one of the world's leading suppliers of chemical building blocks based on chlorine and acetic acid and is the world market leader in monochloroacetic acid (MCAA), an essential component used in a wide range of applications ranging from herbicides, personal care to the food industry. It is also a leading custom manufacturer for global agrochemical, food, pharma and chemical companies.

 

Company

CABB AG

Rheinstraße
4133 Pratteln 1
Switzerland

Company contact







Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.